Granite Investment Partners, LLC Glaukos Corp Transaction History

Granite Investment Partners, LLC

$2.21 Billion
Q4 2024

A detailed history of Granite Investment Partners, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Granite Investment Partners, LLC holds 21,845 shares of GKOS stock, worth $1.96 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

21,845

Previous 23,559 7.28%

Holding current value

$1.96 Million

Previous $3.07 Million 6.71%

% of portfolio

0.15%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$126.42 - $152.67 $216,683 - $261,676	-1,714 Reduced 7.28%	21,845 $3.28 Million
Q3 2024 Nov 12, 2024	SELL	$113.62 - $135.39 $585,370 - $697,529	-5,152 Reduced 17.94%	23,559 $3.07 Million
Q2 2024 Aug 12, 2024	SELL	$89.48 - $118.35 $2,147 - $2,840	-24 Reduced 0.08%	28,711 $3.4 Million
Q1 2024 May 13, 2024	SELL	$76.4 - $96.33 $1.12 Million - $1.41 Million	-14,606 Reduced 33.7%	28,735 $2.71 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $488,741 - $698,753	-8,210 Reduced 15.93%	43,341 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $6,507 - $7,434	-94 Reduced 0.18%	51,551 $3.88 Million
Q2 2023 Aug 07, 2023	SELL	$45.44 - $71.21 $440,222 - $689,882	-9,688 Reduced 15.8%	51,645 $3.68 Million
Q1 2023 May 03, 2023	BUY	$43.88 - $52.48 $79,378 - $94,936	1,809 Added 3.04%	61,333 $3.07 Million
Q4 2022 Feb 10, 2023	BUY	$40.82 - $57.75 $462,857 - $654,827	11,339 Added 23.53%	59,524 $2.6 Million
Q3 2022 Oct 24, 2022	BUY	$46.84 - $58.49 $23,982 - $29,946	512 Added 1.07%	48,185 $2.57 Million
Q2 2022 Jul 22, 2022	SELL	$34.86 - $63.77 $476,466 - $871,608	-13,668 Reduced 22.28%	47,673 $2.17 Million
Q1 2022 May 02, 2022	SELL	$44.33 - $57.82 $760,614 - $992,075	-17,158 Reduced 21.86%	61,341 $3.55 Million
Q4 2021 Feb 10, 2022	BUY	$40.27 - $56.99 $576,626 - $816,039	14,319 Added 22.31%	78,499 $3.49 Million
Q3 2021 Nov 03, 2021	BUY	$47.43 - $84.23 $774,057 - $1.37 Million	16,320 Added 34.1%	64,180 $3.09 Million
Q2 2021 Jul 30, 2021	SELL	$73.06 - $97.7 $607,932 - $812,961	-8,321 Reduced 14.81%	47,860 $4.06 Million
Q1 2021 May 13, 2021	SELL	$70.43 - $97.42 $486,037 - $672,295	-6,901 Reduced 10.94%	56,181 $4.72 Million
Q4 2020 Feb 12, 2021	SELL	$48.9 - $75.26 $127,091 - $195,600	-2,599 Reduced 3.96%	63,082 $4.75 Million
Q3 2020 Nov 06, 2020	BUY	$37.23 - $50.97 $174,720 - $239,202	4,693 Added 7.69%	65,681 $3.25 Million
Q2 2020 Aug 03, 2020	SELL	$28.78 - $46.83 $23,225 - $37,791	-807 Reduced 1.31%	60,988 $2.34 Million
Q1 2020 May 14, 2020	SELL	$25.53 - $70.14 $4.08 Million - $11.2 Million	-159,712 Reduced 72.1%	61,795 $1.91 Million
Q4 2019 Feb 10, 2020	BUY	$54.18 - $65.64 $681,584 - $825,751	12,580 Added 6.02%	221,507 $12.1 Million
Q3 2019 Nov 12, 2019	BUY	$58.58 - $83.91 $603,549 - $864,524	10,303 Added 5.19%	208,927 $13.1 Million
Q2 2019 Aug 07, 2019	SELL	$63.59 - $78.71 $6.04 Million - $7.48 Million	-95,048 Reduced 32.37%	198,624 $15 Million
Q1 2019 May 13, 2019	BUY	$50.75 - $80.54 $2.06 Million - $3.27 Million	40,555 Added 16.02%	293,672 $23 Million
Q4 2018 Feb 13, 2019	SELL	$52.18 - $67.93 $8.73 Million - $11.4 Million	-167,216 Reduced 39.78%	253,117 $14.2 Million
Q3 2018 Nov 08, 2018	BUY	$38.13 - $68.37 $536,412 - $961,829	14,068 Added 3.46%	420,333 $27.3 Million
Q2 2018 Aug 06, 2018	SELL	$27.62 - $44.51 $994,761 - $1.6 Million	-36,016 Reduced 8.14%	406,265 $16.5 Million
Q1 2018 May 04, 2018	BUY	$26.05 - $34.5 $10.3 Million - $13.6 Million	393,906 Added 814.28%	442,281 $13.6 Million
Q4 2017 Feb 01, 2018	BUY	$24.5 - $36.01 $84,868 - $124,738	3,464 Added 7.71%	48,375 $1.24 Million
Q3 2017 Nov 08, 2017	BUY	$31.26 - $42.03 $1.4 Million - $1.89 Million	44,911	44,911 $1.48 Million

Others Institutions Holding GKOS

# of Institutions

346

Shares Held

48M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.27B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Account

Granite Investment Partners, LLC Glaukos Corp Transaction History